These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 9441917)
1. Hazard assessment of boric acid in toys. Craan AG; Myres AW; Green DW Regul Toxicol Pharmacol; 1997 Dec; 26(3):271-80. PubMed ID: 9441917 [TBL] [Abstract][Full Text] [Related]
2. Risk assessment of oral exposure to diisononyl phthalate from children's products. Babich MA; Chen SB; Greene MA; Kiss CT; Porter WK; Smith TP; Wind ML; Zamula WW Regul Toxicol Pharmacol; 2004 Oct; 40(2):151-67. PubMed ID: 15450718 [TBL] [Abstract][Full Text] [Related]
3. The potential health effects of phthalate esters in children's toys: a review and risk assessment. Wilkinson CF; Lamb JC Regul Toxicol Pharmacol; 1999 Oct; 30(2 Pt 1):140-55. PubMed ID: 10536109 [TBL] [Abstract][Full Text] [Related]
4. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials. EFSA GMO Panel Working Group on Animal Feeding Trials Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408 [TBL] [Abstract][Full Text] [Related]
5. A comparative review of the pharmacokinetics of boric acid in rodents and humans. Murray FJ Biol Trace Elem Res; 1998; 66(1-3):331-41. PubMed ID: 10050928 [TBL] [Abstract][Full Text] [Related]
6. Using physiologically-based pharmacokinetic modeling to address nonlinear kinetics and changes in rodent physiology and metabolism due to aging and adaptation in deriving reference values for propylene glycol methyl ether and propylene glycol methyl ether acetate. Kirman CR; Sweeney LM; Corley R; Gargas ML Risk Anal; 2005 Apr; 25(2):271-84. PubMed ID: 15876203 [TBL] [Abstract][Full Text] [Related]
7. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice. Marsman D Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194 [TBL] [Abstract][Full Text] [Related]
8. Final amended report on the safety assessment of Methylparaben, Ethylparaben, Propylparaben, Isopropylparaben, Butylparaben, Isobutylparaben, and Benzylparaben as used in cosmetic products. Int J Toxicol; 2008; 27 Suppl 4():1-82. PubMed ID: 19101832 [TBL] [Abstract][Full Text] [Related]
9. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin. Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137 [TBL] [Abstract][Full Text] [Related]
11. Background to the ADI/TDI/PTWI. Herrman JL; Younes M Regul Toxicol Pharmacol; 1999 Oct; 30(2 Pt 2):S109-13. PubMed ID: 10597623 [TBL] [Abstract][Full Text] [Related]
12. Utilization of juvenile animal studies to determine the human effects and risks of environmental toxicants during postnatal developmental stages. Brent RL Birth Defects Res B Dev Reprod Toxicol; 2004 Oct; 71(5):303-20. PubMed ID: 15505806 [TBL] [Abstract][Full Text] [Related]
13. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice. Beland FA Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702 [TBL] [Abstract][Full Text] [Related]
14. Precision of estimates of an ADI (or TDI or PTWI). Speijers GJ Regul Toxicol Pharmacol; 1999 Oct; 30(2 Pt 2):S87-93. PubMed ID: 10597619 [TBL] [Abstract][Full Text] [Related]
15. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289 [TBL] [Abstract][Full Text] [Related]
16. Final report of the safety assessment of Alcohol Denat., including SD Alcohol 3-A, SD Alcohol 30, SD Alcohol 39, SD Alcohol 39-B, SD Alcohol 39-C, SD Alcohol 40, SD Alcohol 40-B, and SD Alcohol 40-C, and the denaturants, Quassin, Brucine Sulfate/Brucine, and Denatonium Benzoate. Cosmetic Ingredient Review Expert Panel Int J Toxicol; 2008; 27 Suppl 1():1-43. PubMed ID: 18569160 [TBL] [Abstract][Full Text] [Related]
17. [Investigation of the pharmacodynamic properties of the solution of boric acid]. Drobnik M; Latour T Rocz Panstw Zakl Hig; 2001; 52(4):329-36. PubMed ID: 11878014 [TBL] [Abstract][Full Text] [Related]
18. [Meta-analysis of the Italian studies on short-term effects of air pollution]. Biggeri A; Bellini P; Terracini B; Epidemiol Prev; 2001; 25(2 Suppl):1-71. PubMed ID: 11515188 [TBL] [Abstract][Full Text] [Related]
19. Developmental effects of boric acid in rats related to maternal blood boron concentrations. Price CJ; Strong PL; Murray FJ; Goldberg MM Biol Trace Elem Res; 1998; 66(1-3):359-72. PubMed ID: 10050930 [TBL] [Abstract][Full Text] [Related]
20. Health effect levels for risk assessment of childhood exposure to arsenic. Tsuji JS; Benson R; Schoof RA; Hook GC Regul Toxicol Pharmacol; 2004 Apr; 39(2):99-110. PubMed ID: 15041143 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]